Day: February 2, 2023

Erickson Senior Living Standardizes and Modernizes Physical Security Across its Enterprise with Genetec Security Center

user February 2, 2023

Company unifies video surveillance, access control, license plate recognition and more to improve security and the resident experience MONTRÉAL, February...

Frontera Therapeutics Doses First Patient in a Clinical Trial of FT-003 Gene Therapy for the Treatment of Wet AMD

Staff February 2, 2023

BEDFORD, Mass. and SHANGHAI, China, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Frontera Therapeutics, a global clinical-stage biotechnology company that seeks...

Inovalon Adds All-payer Claims Management Software to the PointClickCare Marketplace, Expanding Partnership

Staff February 2, 2023

Latest EHR Integration from Inovalon Offers Healthcare Providers 99% First Pass Claims Acceptance RateBOWIE, Md., Feb. 02, 2023 (GLOBE NEWSWIRE)...

Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss

Staff February 2, 2023

Expects to Commence Phase 2a of CAReS During the First Quarter of 2023SOLANA BEACH, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE)...

Y-mAbs and the European Medicines Agency Reach Agreement on the Pediatric Investigation Plan for Naxitamab

Staff February 2, 2023

NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...

International Myeloma Foundation (IMF) Returns to In-Person Patient and Family Seminars in 2023, Announces Boca Raton Event

Staff February 2, 2023

BOCA RATON, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that this year’s first...

BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm

Staff February 2, 2023

HENDERSON, NV, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has entered into...

Ashvattha Therapeutics to Present at Upcoming Investor Conferences

Staff February 2, 2023

REDWOOD CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company leveraging its nanomedicine technology, hydroxyl...

Day: February 2, 2023

Erickson Senior Living Standardizes and Modernizes Physical Security Across its Enterprise with Genetec Security Center

Frontera Therapeutics Doses First Patient in a Clinical Trial of FT-003 Gene Therapy for the Treatment of Wet AMD

Inovalon Adds All-payer Claims Management Software to the PointClickCare Marketplace, Expanding Partnership

Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss

Y-mAbs and the European Medicines Agency Reach Agreement on the Pediatric Investigation Plan for Naxitamab

International Myeloma Foundation (IMF) Returns to In-Person Patient and Family Seminars in 2023, Announces Boca Raton Event

BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm

Ashvattha Therapeutics to Present at Upcoming Investor Conferences

Canadian Red Cross opens appeal to support people impacted by flooding in Manitoba

GuideAI Health Announces Marketing and Communications Programs

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

SoliVana Wellness Lab Celebrates 3 years in Redwood City as the Bay Area’s First Dedicated Nervous System Recovery Center

Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

You may have missed